Condition (MeSH)
Scorpion Stings
ClinicalTrials.gov lists 14 trials for Scorpion Stings or a narrower condition beneath it. Instituto Bioclon S.A. de C.V. has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
14 of the 14 trials are tagged with Scorpion Stings itself; the rest are tagged with a narrower condition beneath it.
When did Scorpion Stings trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 2 |
| 2020 | 2 |
| 2019 | 1 |
| 2017 | 1 |
| 2011 | 1 |
| 2008 | 1 |
| 2006 | 1 |
| 2005 | 1 |
| 2004 | 2 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 14 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Scorpion Stings trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 3 |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 3 |
| Observational | 4 |
How many Scorpion Stings trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Completed | 11 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Scorpion Stings trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Instituto Bioclon S.A. de C.V. | 3 |
| Haffkine Bio-Pharmaceutical Corporation Ltd. | 1 |
Which drugs are being tested for Scorpion Stings? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Anascorp | 1 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Antiscorpion venom serum(AScVS). | 1 |
| Antivenin Centruroides (scorpion) equine immune F(ab')2 | 1 |
| Lidocaine Topical | 1 |
| Serial dose of scorpion antivenom regimen | 1 |
| Anti-scorpion venom serum Birmex | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Scorpion Stings? (20)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A comparative study of using scorpion antivenom versus scorpion antivenom and prazosin drug for scorpion stings management in Sohag University Hospitals. | BMC pharmacology & toxicology | 2025 | Yes |
| Terrestrial venomous animals, the envenomings they cause, and treatment perspectives in the Middle East and North Africa. | PLoS neglected tropical diseases | 2021 | Yes |
| Scorpion envenomation: state of the art. | Intensive care medicine | 2020 | Yes |
| Is there any relationship between initial hematological parameters and severity of scorpion envenomation? | The Turkish journal of pediatrics | 2020 | Yes |
| Clinical Presentation and Outcomes Associated with Different Treatment Modalities for Pediatric Bark Scorpion Envenomation. | Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2017 | Yes |
Showing 5 of 20 publications.
Prevalence (2)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Scorpion envenomation | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Scorpion envenomation | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Scorpion envenomation | 466677 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Scorpion envenomation | 466677 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.